Literature DB >> 15795654

Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population.

Sang Seop Lee1, Kang-Mi Kim, Huong Thi-Le, Sung-Su Yea, In-June Cha, Jae-Gook Shin.   

Abstract

Cytochrome P450 2C9 (CYP2C9) shows genetic polymorphism with high interethnic variation, but no report has addressed the genetic polymorphism in the Vietnamese population. In the present study, the distribution of 2 common allelic variations of CYP2C9 was investigated in Vietnamese Kinh population, a major ethnic group in Vietnam. Genomic DNA from 157 Vietnamese subjects was amplified by polymerase chain reaction, and the presence of CYP2C9*2 and CYP2C9*3 allelic variants was determined by pyrosequencing. Among 157 Vietnamese subjects, no subject with the CYP2C9*2 allele was detected, but 7 subjects were heterozygous for the CYP2C9*3 allele. The allele frequency of CYP2C9*3 was 2.2% in the Vietnamese Kinh population. This genotype distribution was well correlated with previous reports suggesting no occurrence of CYP2C9*2 in Asians. These results suggest that CYP2C9*2 may be absent in Vietnamese Kinh population and that CYP2C9*3 is major allelic variant that causes interindividual variation of drug responses to CYP2C9 substrate drugs in the Vietnamese Kinh population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795654     DOI: 10.1097/01.ftd.0000153402.91854.42

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  10 in total

1.  Use of pyrosequencing to differentiate Streptococcus pneumoniae serotypes 6A and 6B.

Authors:  Rekha Pai; Josef Limor; Bernard Beall
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Polymorphic analysis of CYP2C9 gene in Vietnamese population.

Authors:  Nhung Phuong Vu; Thuong Thi Huyen Ma; Ngoc Thi Bich Tran; Hue Thi Thu Huynh; Ton Dang Nguyen; Duong Thuy Nguyen; Hai Van Nong; Ming Ta Michael Lee; Ha Hai Nguyen
Journal:  Mol Biol Rep       Date:  2018-07-05       Impact factor: 2.316

Review 3.  Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.

Authors:  Elena García-Martín; Carmen Martínez; José M Ladero; José A G Agúndez
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 4.  Implementing genotype-guided antithrombotic therapy.

Authors:  Richard L Seip; Jorge Duconge; Gualberto Ruaño
Journal:  Future Cardiol       Date:  2010-05

Review 5.  Cytochrome P450 2C9-CYP2C9.

Authors:  Derek Van Booven; Sharon Marsh; Howard McLeod; Michelle Whirl Carrillo; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-04       Impact factor: 2.089

6.  Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region.

Authors:  Ekta Varshney; Nilanjan Saha; Monika Tandon; Vikesh Shrivastava; Shakir Ali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-02-28       Impact factor: 2.441

7.  Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.

Authors:  M I Veiga; S Asimus; P E Ferreira; J P Martins; I Cavaco; V Ribeiro; T N Hai; M G Petzold; A Björkman; M Ashton; J P Gil
Journal:  Eur J Clin Pharmacol       Date:  2008-11-01       Impact factor: 2.953

8.  Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.

Authors:  Yipeng Ding; Danlei Yang; Long Zhou; Ping He; Jinjian Yao; Pingdong Xie; Daobo Lin; Dingwei Sun; Pei Sun; Quanni Li; Tingting Geng; Tianbo Jin
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 9.  Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions.

Authors:  Ramón Cacabelos; Vinogran Naidoo; Lola Corzo; Natalia Cacabelos; Juan C Carril
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

10.  Genotyping of CYP2C9 and VKORC1 in the Arabic population of Al-Ahsa, Saudi Arabia.

Authors:  Abdullah M Alzahrani; Georgia Ragia; Hamza Hanieh; Vangelis G Manolopoulos
Journal:  Biomed Res Int       Date:  2013-03-17       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.